A young girl wearing ZEISS MyoCare lenses and looking to the side.

ZEISS FOR EYE CARE PROFESSIONALS

ZEISS MyoCare lens portfolio

Name: ZEISS MyoCare lenses
Brand: ZEISS

A better outlook on life.

Proven to effectively slow the progression of myopia in children, the ZEISS MyoCare lens portfolio is your trusted choice for myopia management. The culmination of over a decade of expertise, innovative MyoCare^® lenses are designed to address progressive myopia while providing clear, comfortable vision – at any angle, all day long.

Get in touch

Innovation trusted around the world.

The ZEISS MyoCare portfolio uses an optical strategy backed by scientific evidence from 18 peer-reviewed publications to correct refractive errors and slow myopia progression. From private practices to university hospitals, eye care professionals in over 100 countries count on MyoCare^® and MyoCare^® S lenses for their young patients.

ZEISS MyoCare lenses

A harder design variant with a smaller clear zone and stronger mean addition power. Recommended as the starter lens for children of all ages.
a Central zone diameter: 7mm

Mean add surface power for microstructures in the b treatment zone: +4.6 D

Fill factor: 0.5
ZEISS MyoCare S lenses

These lenses feature a larger clear zone and softer mean addition power. Recommended for children who have difficulty adapting to ZEISS MyoCare lenses.
a Central zone diameter: 9 mm

Mean add surface power for microstructures in the b treatment zone: +3.8 D

Fill factor: 0.5

Explore the ZEISS MyoCare portfolio.

Third-party Content Blocked

The video player is blocked due to your cookie preferences. To change the settings and play the video, please click the button below and consent to use of "Functional" tracking technologies.

Wearers approve.

95%

of children adapted to their ZEISS MyoCare or MyoCare S lenses within three days.¹
92%

of all participants subjectively rated vision with ZEISS MyoCare lenses as very good for far distances.¹
94%

of wearers rated vision with ZEISS MyoCare or MyoCare S lenses as very good for near distances.¹

Efficacy confirmed: Up to 3.5x reduced occurrence of fast myopia progression with ZEISS MyoCare.

MyoCare^® lenses proved effective in slowing myopia progression in extensive clinical testing conducted on two different continents: They can reduce the occurrence of fast myopia progression by up to 3.5 times.²

Two different multicentre clinical trials in China (NCT 05288335) and Europe (NCT 05919654) demonstrated that ZEISS MyoCare lens designs can help slow myopia progression compared to ZEISS single vision lenses. The rate of progression among children wearing MyoCare^® and MyoCare^®S lenses was significantly reduced in the first and second years of the clinical trial.

An eye care professional handing eyeglasses with ZEISS MyoCare lenses to a young patient.

The 24-month results of the randomised multi clinical trial in China show a significant difference in axial length change and spherical equivalent refraction error change between the untreated group wearing single vision lenses and the treatment group wearing ZEISS MyoCare lens designs.¹

A smiling young girl wearing ZEISS MyoCare lenses.

Effective innovation – from front to back.

The ZEISS MyoCare portfolio combines a central clear zone, a treatment zone with microstructures and the specific back surface design – making it an effective solution for children.

A close-up image of a child wearing ZEISS MyoCare lenses. The lens shows an illustrative outline of the central zone, treatment zone and fill factor in ZEISS MyoCare lenses with ZEISS C.A.R.E. technology.

Managing myopia with clarity. Front surface.

An effective myopia management lens must overcome certain design challenges to manage the progression of myopia while providing good vision. This is precisely why ZEISS has developed ZEISS C.A.R.E technology (Cylindrical Annular Refractive Elements). In addition, we have included the following in our ZEISS Myopia Management solutions:

A central zone small enough to establish an effective functional zone, projecting myopic defocus on the near periphery close to the fovea.
A mean addition surface power to induce the intended relative myopia defocus.
A carefully selected fill factor to deliver high efficacy while preserving good wearability.

Learn more about ZEISS C.A.R.E. technology

Creating simultaneous competing defocus.

To achieve the optimum balance of features that enable effective myopia progression control, clear vision for day-to-day activities, and good wearability, ZEISS MyoCare lens design incorporates C.A.R.E.^® technology (Cylindrical Annular Refractive Elements) delivering simultaneous competing defocus.

The central zone is a circular area around the „zero axis“ of the lens providing clear and sharp vision for straight ahead gaze.

An illustration of a ZEISS MyoCare lens with ZEISS C.A.R.E. technology, highlighting the clear central zone in the middle oft he lens.

The clear zone is surrounded by the treatment zone which expands towards the periphery of the lens. It consists of alternating defocusing elements (ZEISS C.A.R.E technology) and regular correction zones.

An illustration of a ZEISS MyoCare lens with ZEISS C.A.R.E. technology, highlighting the ring-shape pattern of the treatment zone.

The relation of the distribution between these rings is called the fill factor, which is 0.5 for all ZEISS MyoCare designs. This means there is a ratio of 50:50, balancing the defocus and correction areas and providing the balance for effectivity and wearability.

An illustration of a ZEISS MyoCare lens with ZEISS C.A.R.E. technology, highlighting the fill factor, the spaces between the ring-shapes of the treatment zone.

A smiling young girl wearing ZEISS MyoCare lenses in class working on papers.

Keeping up with moving eyes.

ZEISS ClearFocus design

In contrast to contact lenses, spectacle lenses must account for eye movement to maintain the intended correction and myopic defocus across all gaze angles.

Conventional spherical single vision lenses perform poorly, especially when it comes to peripheral vision. They can expose myopic children to hyperopic defocus, which can cause further myopia progression.

ZEISS MyoCare lenses address this issue with the ZEISS ClearFocus design, a point-by-point freeform optimised back surface design. This design ensures optimal vision correction and intended myopic defocus for all gaze directions while minimising hyperopic defocus.

Learn more about ZEISS ClearFocus design

Effectively minimise the induction of hyperopic defocus.

With spherical single vision lenses, myopic children are exposed to hyperopic defocus introduced by the optical aberrations in the lens periphery. Hyperopic defocus is a known trigger for axial elongation and further myopisation. These optical aberrations would result in a reduction of the intended myopic defocus from the cylindrical annular refractive elements in the functional zone.

An illustration of a myopic eye looking through the periphery of a conventional single vision lens with the focal point being behind the retina.

With ZEISS ClearFocus design, both the optimal refractive correction and the intended myopic defocus are maintained for all gaze directions. In addition, ZEISS ClearFocus design effectively minimises the induction of hyperopic defocus as opposed to typical spherical single vision lenses.

An illustration of a myopic eye looking through the periphery of a ZEISS MyoCare lens with ZEISS ClearFocus design where multiple focal points are corrected and focused onto the retina.

Contact Us

Interested in becoming a ZEISS partner?

Please provide your information so that a ZEISS representative can contact you.

Form is loading...

The information entered in the contact form will be used to answer your request by Carl Zeiss Vision International GmbH by E-Mail or phone. Click here to read our statement on data protection.

Do you have another request?

Let us know what we can do for you.